Westpac Banking Corp’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $768K | Buy |
+13,980
| New | +$768K | 0.05% | 231 |
|
2025
Q1 | – | Sell |
-3,501
| Closed | -$230K | – | 470 |
|
2024
Q4 | $230K | Buy |
3,501
+1,414
| +68% | +$92.9K | 0.02% | 350 |
|
2024
Q3 | $147K | Hold |
2,087
| – | – | 0.01% | 404 |
|
2024
Q2 | $172K | Hold |
2,087
| – | – | 0.01% | 339 |
|
2024
Q1 | $182K | Hold |
2,087
| – | – | 0.01% | 356 |
|
2023
Q4 | $201K | Buy |
2,087
+735
| +54% | +$70.9K | 0.02% | 338 |
|
2023
Q3 | $120K | Hold |
1,352
| – | – | 0.01% | 431 |
|
2023
Q2 | $117K | Sell |
1,352
-16,102
| -92% | -$1.4M | 0.01% | 409 |
|
2023
Q1 | $1.7M | Buy |
17,454
+3,923
| +29% | +$381K | 0.02% | 551 |
|
2022
Q4 | $1.4M | Buy |
13,531
+355
| +3% | +$36.7K | 0.02% | 552 |
|
2022
Q3 | $1.12M | Hold |
13,176
| – | – | 0.02% | 600 |
|
2022
Q2 | $1.09M | Hold |
13,176
| – | – | 0.01% | 652 |
|
2022
Q1 | $1.02M | Hold |
13,176
| – | – | 0.01% | 689 |
|
2021
Q4 | $1.16M | Buy |
13,176
+997
| +8% | +$88.1K | 0.01% | 668 |
|
2021
Q3 | $941K | Hold |
12,179
| – | – | 0.01% | 734 |
|
2021
Q2 | $1.02M | Hold |
12,179
| – | – | 0.01% | 750 |
|
2021
Q1 | $920K | Hold |
12,179
| – | – | 0.01% | 706 |
|
2020
Q4 | $1.07M | Hold |
12,179
| – | – | 0.01% | 714 |
|
2020
Q3 | $927K | Hold |
12,179
| – | – | 0.01% | 677 |
|
2020
Q2 | $1.5M | Hold |
12,179
| – | – | 0.02% | 561 |
|
2020
Q1 | $1.03M | Hold |
12,179
| – | – | 0.02% | 582 |
|
2019
Q4 | $1.03M | Hold |
12,179
| – | – | 0.01% | 676 |
|
2019
Q3 | $821K | Hold |
12,179
| – | – | 0.01% | 692 |
|
2019
Q2 | $1.04M | Hold |
12,179
| – | – | 0.02% | 546 |
|
2019
Q1 | $1.08M | Hold |
12,179
| – | – | 0.02% | 531 |
|
2018
Q4 | $1.04M | Buy |
12,179
+2,161
| +22% | +$184K | 0.02% | 571 |
|
2018
Q3 | $971K | Hold |
10,018
| – | – | 0.02% | 545 |
|
2018
Q2 | $944K | Hold |
10,018
| – | – | 0.02% | 508 |
|
2018
Q1 | $812K | Hold |
10,018
| – | – | 0.02% | 532 |
|
2017
Q4 | $893K | Hold |
10,018
| – | – | 0.02% | 485 |
|
2017
Q3 | $932K | Hold |
10,018
| – | – | 0.02% | 518 |
|
2017
Q2 | $910K | Sell |
10,018
-3,281
| -25% | -$298K | 0.02% | 525 |
|
2017
Q1 | $1.17M | Sell |
13,299
-6
| -0% | -$527 | 0.01% | 614 |
|
2016
Q4 | $1.11M | Buy |
13,305
+499
| +4% | +$41.5K | 0.01% | 554 |
|
2016
Q3 | $1.18M | Buy |
12,806
+3,879
| +43% | +$359K | 0.01% | 528 |
|
2016
Q2 | $695K | Buy |
8,927
+2,050
| +30% | +$159K | 0.01% | 663 |
|
2016
Q1 | $567K | Sell |
6,877
-2,633
| -28% | -$217K | 0.01% | 650 |
|
2015
Q4 | $996K | Sell |
9,510
-42,667
| -82% | -$4.47M | 0.01% | 572 |
|
2015
Q3 | $5.5M | Sell |
52,177
-46,684
| -47% | -$4.92M | 0.06% | 296 |
|
2015
Q2 | $13.5M | Buy |
98,861
+84,993
| +613% | +$11.6M | 0.13% | 149 |
|
2015
Q1 | $1.87M | Sell |
13,868
-1,550
| -10% | -$209K | 0.02% | 516 |
|
2014
Q4 | $1.39M | Buy |
15,418
+434
| +3% | +$39.2K | 0.01% | 556 |
|
2014
Q3 | $1.08M | Buy |
14,984
+5,399
| +56% | +$390K | 0.01% | 599 |
|
2014
Q2 | $596K | Sell |
9,585
-140
| -1% | -$8.71K | 0.01% | 709 |
|
2014
Q1 | $663K | Buy |
9,725
+1,100
| +13% | +$75K | 0.01% | 654 |
|
2013
Q4 | $606K | Buy |
8,625
+181
| +2% | +$12.7K | 0.01% | 703 |
|
2013
Q3 | $610K | Buy |
8,444
+2,544
| +43% | +$184K | 0.01% | 678 |
|
2013
Q2 | $329K | Buy |
+5,900
| New | +$329K | 0.01% | 813 |
|